TITLE

Low T: Disease, the Gold Mine

AUTHOR(S)
Retsinas, Joan
PUB. DATE
December 2013
SOURCE
Progressive Populist;12/1/2013, Vol. 19 Issue 21, p15
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The author details how the pharmaceutical industry and some entrepreneurs earn large profits by inventing a disease and developing a cure for it, citing low-testosterone as an example, with marketers convincing men that they must boost their testosterone levels in spite of a lack of medical data.
ACCESSION #
91997826

 

Related Articles

  • WHY DRUG COMPANIES ARE THE MOST PROFITABLE U.S. INDUSTRY.  // Health & Stress;2003, Issue 2, p1 

    Reports that pharmaceutical companies continued their supremacy as the most profitable industry the United States in 2001. Profits earned by Fortune 500 pharmaceutical companies; Shift to more expensive prescriptions; Factors that have allowed drug companies to gain substantial profits.

  • Old Copycats: Learn New Tricks. Desai, V. Subhash // Siliconindia;Mar2002, Vol. 6 Issue 3, p10 

    Focuses on the aspects of the pharmaceutical industry in India. Overview on the average profits and revenues of pharmaceutical companies; Complexities facing large and small pharmaceutical firms; Profitability and risks with drug discovery.

  • IMS Health Business Watch. Friedman, Katherine; Kulp, Katrina // Medical Marketing & Media;May2000, Vol. 35 Issue 5, p40 

    Reports on the increase in the sales for the United States pharmaceutical industry for the year 1999. Increase in sales due to increased use of medicine; Anti-ulcer drugs' domination of the market; Percentage of drug purchases from retail pharmacies.

  • Key pharmaceutical markets expect growth through 2005.  // Fairfield County Business Journal;04/16/2001, Vol. 40 Issue 16, p25 

    Focuses on the expected growth of pharmaceutical markets in Latin America. Average rate of sales expansion; Expected annual sales in Mexico; Factors affecting the pharmaceutical industry; Influence of currency changes on pharmaceutical sales; Projected healthcare market status.

  • Drug Industry Most Profitable.  // HealthFacts;May2002, Vol. 27 Issue 5, p3 

    Reports on the profitability of the drug industry in the U.S., according to the organization FamiliesUSA.

  • Big Pharma Pursues Top Position in Japanese Market. Jarvis, Lisa // Chemical Market Reporter;10/7/2002, Vol. 262 Issue 12, p10 

    Presents top ten Japanese pharmaceutical companies forecasts for the year 2002. List of small companies that needed mergers; Total revenues generated by the companies; Issuance of bold objectives for penetration of pharmaceutical companies in the U.S. market.

  • Drug Chain Annual Report.  // Drug Store News;4/28/2003, Vol. 25 Issue 6, p1 

    Reports on the profit performance of the pharmaceutical industry in the U.S.

  • Hungary Egis, Richter to release Q412 earnings figures.  // Hungary A.M.;02/04/2013, p2 

    The article reports on the projected substantial net profit increase of Hungarian pharmaceutical producers in the fourth quarter of 2012.

  • Pharmaceutical companies' 2Q earnings are a mixed bag. Martinez, Marialba // Caribbean Business;8/8/2002, Vol. 30 Issue 32, p14 

    Reports on the financial performance of U.S. pharmaceutical companies during the second quarter of 2002. Sales of Pharmacia Corp.; Net income of Wyeth; Key growth-driver products for Abbott Laboratories; Product sales of Bristol-Myers Squibb Co.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics